Trial Profile
Biodegradable polymer sirolimus- eluting stent (BP-SES) clinical outcomes in patients with acute coronary syndrome in Italy: A real world data from ULISSE registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2020
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Myocardial infarction
- Focus Therapeutic Use
- 31 Oct 2018 New trial record
- 25 Sep 2018 Results presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics